Response to: COVID-19-associated mucormycosis and evolving evidence.

Sarda, R; Swain, S; Ray, A; Wig, N

Sarda, R; Swain, S; Ray, A; Wig, N.

Sarda R; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.
Swain S; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.
Ray A; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.
Wig N; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.

QJM ; 115(6): 422, 2022 06 07.

Article in English | MEDLINE | ID: covidwho-1878816

Subject(s)

COVID-19; Mucormycosis; Humans; Mucormycosis/complications; Mucormycosis/diagnosis; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mucormycosis Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google